- Home
- ANIX vs JHS Comparison
ANIX vs JHS Comparison
Compare ANIX & JHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- JHS
- Stock Information
- Founded
- ANIX 1982
- JHS 1973
- Country
- ANIX United States
- JHS United States
- Employees
- ANIX 5
- JHS N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- JHS Finance Companies
- Sector
- ANIX Health Care
- JHS Finance
- Exchange
- ANIX Nasdaq
- JHS Nasdaq
- Market Cap
- ANIX 135.3M
- JHS 131.4M
- IPO Year
- ANIX 1987
- JHS N/A
- Fundamental
- Price
- ANIX $4.14
- JHS $11.61
- Analyst Decision
- ANIX Strong Buy
- JHS
- Analyst Count
- ANIX 3
- JHS 0
- Target Price
- ANIX $9.00
- JHS N/A
- AVG Volume (30 Days)
- ANIX 155.7K
- JHS 32.8K
- Earning Date
- ANIX 09-10-2025
- JHS 01-01-0001
- Dividend Yield
- ANIX N/A
- JHS 3.96%
- EPS Growth
- ANIX N/A
- JHS N/A
- EPS
- ANIX N/A
- JHS 0.02
- Revenue
- ANIX N/A
- JHS N/A
- Revenue This Year
- ANIX N/A
- JHS N/A
- Revenue Next Year
- ANIX N/A
- JHS N/A
- P/E Ratio
- ANIX N/A
- JHS $553.50
- Revenue Growth
- ANIX N/A
- JHS N/A
- 52 Week Low
- ANIX $2.07
- JHS $9.76
- 52 Week High
- ANIX $4.98
- JHS $11.25
- Technical
- Relative Strength Index (RSI)
- ANIX 52.15
- JHS 54.43
- Support Level
- ANIX $4.05
- JHS $11.48
- Resistance Level
- ANIX $4.60
- JHS $11.64
- Average True Range (ATR)
- ANIX 0.24
- JHS 0.10
- MACD
- ANIX -0.02
- JHS 0.01
- Stochastic Oscillator
- ANIX 48.05
- JHS 95.65
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About JHS John Hancock Income Securities Trust
John Hancock Income Securities Trust is a United States-based closed-ended diversified management investment company. Its primary objective is to generate a high level of current income consistent with prudent investment risk. The fund invests its net assets (plus borrowings for investment purposes) in income securities, consisting of marketable corporate debt securities, governmental obligations, and cash and commercial paper. A majority of its net assets are invested in debt securities that are rated, at the time of acquisition, investment-grade or in unrated securities determined by the Fund's investment advisor or subadvisor to be of comparable credit quality.